Timothy P Clackson - Net Worth and Insider Trading
Timothy P Clackson Net Worth
The estimated net worth of Timothy P Clackson is at least $6 Million dollars as of 2024-11-13. Timothy P Clackson is the President, R&D, CSO of ARIAD Pharmaceuticals Inc and owns about 197,884 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $5 Million. Timothy P Clackson is also the President and CEO of Theseus Pharmaceuticals Inc and owns about 351,030 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $1 Million. Details can be seen in Timothy P Clackson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy P Clackson has not made any transactions after 2022-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy P Clackson
Timothy P Clackson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy P Clackson owns 7 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , Forma Therapeutics Holdings Inc (FMTX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Timothy P Clackson’s form 4 insider trades.
Insider Ownership Summary of Timothy P Clackson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-09-30 | director |
| FMTX | Forma Therapeutics Holdings Inc | 2020-06-18 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | President & R&D & CSO |
 | | 2018-03-01 | director |
| | 2022-11-11 | director & President and CEO |
| | 2021-06-24 | director |
| | 2021-10-21 | 10 percent owner |
Timothy P Clackson Latest Holdings Summary
Timothy P Clackson currently owns a total of 2 stocks. Among these stocks, Timothy P Clackson owns 197,884 shares of ARIAD Pharmaceuticals Inc (ARIA) as of October 24, 2016, with a value of $5 Million and a weighting of 76.91%. Timothy P Clackson also owns 351,030 shares of Theseus Pharmaceuticals Inc (THRX) as of November 11, 2022, with a value of $1 Million and a weighting of 23.09%.
Latest Holdings of Timothy P Clackson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-10-24 | 197,884 | 23.99 | 4,747,237 |
| THRX | Theseus Pharmaceuticals Inc | 2022-11-11 | 351,030 | 4.06 | 1,425,182 |
Holding Weightings of Timothy P Clackson
Timothy P Clackson Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy P Clackson has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 19,638 shares on October 24, 2016, which brought Timothy P Clackson around $187,739.
According to the SEC Form 4 filings, Timothy P Clackson has made a total of 2 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 2,500 shares on November 11, 2022, which cost Timothy P Clackson around $17,000.
Insider Trading History of Timothy P Clackson
- 1
Timothy P Clackson Trading Performance
GuruFocus tracks the stock performance after each of Timothy P Clackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy P Clackson is 71.58%. GuruFocus also compares Timothy P Clackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy P Clackson within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy P Clackson's insider trading performs compared to the benchmark.
Performance of Timothy P Clackson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.01 | | | | | |
| Relative Return to S&P 500(%) | 2.19 | | | | | |
Timothy P Clackson Ownership Network
Ownership Network List of Timothy P Clackson
Ownership Network Relation of Timothy P Clackson
Timothy P Clackson Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Timothy P Clackson is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Timothy P Clackson Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy P Clackson. You might contact Timothy P Clackson via mailing address: C/o Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
